[logo] HealthTree Foundation
search person

Daratumumab (Darzalex) Financial Assistance Program

Posted: Jan 27, 2017
Daratumumab (Darzalex) Financial Assistance Program image

Patient assistance programs are available for some commonly used myeloma treatments - for the drug costs themselves and/or for co-pay assistance. Many of these programs are significantly underutilized, so please call and find out if these programs apply to you, even if you are not financially distressed.  The following support is offered by Janssen for the drug daratumumab (DARZALEX®).

If You Have Commercial Insurance

Janssen CarePath Savings Program for DARZALEX®
The Janssen CarePath Savings Program for DARZALEX® may provide a rebate for your out-of-pocket DARZALEX® costs. If eligible, you will pay no more than $10 per infusion. For infusions 1-8, you pay $5 per infusion. For infusions 9+, you pay $10 per infusion. Maximum benefit per calendar year is $15,000. Not valid for patients enrolled in Medicare or Medicaid. Other restrictions may apply. Rebates are determined by medication cost only and not the cost associated with intravenous (IV) infusion. For additional details, including complete eligibility and restrictions, please visit ww.CarePathSavingsProgram.com/DARZALEX or call 877-CarePath (877-227-3728).

If You Have Medicare

Janssen CarePath can refer you to the Medicare Savings Program to discuss eligibility and program benefits. To learn more about eligibility and how the Medicare Savings Program can help you pay for Medicare Part B products, visit www.Medicare.gov/contacts, click on the link for “Medicare Savings Programs (MSPs)” under “Other helpful websites,” and select the appropriate state.

If You Have Medicare, Medicaid, TRICARE, or Commercial Insurance

If eligible, you may be able to receive cost assistance through .

Other Resources

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to uninsured patients who lack the financial resources to pay for their medicines. If you need DARZALEX® and are uninsured and unable to pay for your medicine, please contact a JJPAF program specialist at 1-800-652-6227, 9:00 am to 6:00 pm ET, or visit the foundation website at www.JJPAF.org to see if you might qualify for assistance. For more information on these programs, please call Janssen CarePath at 1-844-55DARZA (1-844-553-2792), Monday through Friday, 8:00 am to 8:00 pm ET, and speak to a Janssen CarePath Care Coordinator. For a comprehensive list of cost support programs related to DARZALEX®, visit www.JanssenPrescriptionAssistance.com/DARZALEX.

Patient assistance programs are available for some commonly used myeloma treatments - for the drug costs themselves and/or for co-pay assistance. Many of these programs are significantly underutilized, so please call and find out if these programs apply to you, even if you are not financially distressed.  The following support is offered by Janssen for the drug daratumumab (DARZALEX®).

If You Have Commercial Insurance

Janssen CarePath Savings Program for DARZALEX®
The Janssen CarePath Savings Program for DARZALEX® may provide a rebate for your out-of-pocket DARZALEX® costs. If eligible, you will pay no more than $10 per infusion. For infusions 1-8, you pay $5 per infusion. For infusions 9+, you pay $10 per infusion. Maximum benefit per calendar year is $15,000. Not valid for patients enrolled in Medicare or Medicaid. Other restrictions may apply. Rebates are determined by medication cost only and not the cost associated with intravenous (IV) infusion. For additional details, including complete eligibility and restrictions, please visit ww.CarePathSavingsProgram.com/DARZALEX or call 877-CarePath (877-227-3728).

If You Have Medicare

Janssen CarePath can refer you to the Medicare Savings Program to discuss eligibility and program benefits. To learn more about eligibility and how the Medicare Savings Program can help you pay for Medicare Part B products, visit www.Medicare.gov/contacts, click on the link for “Medicare Savings Programs (MSPs)” under “Other helpful websites,” and select the appropriate state.

If You Have Medicare, Medicaid, TRICARE, or Commercial Insurance

If eligible, you may be able to receive cost assistance through .

Other Resources

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to uninsured patients who lack the financial resources to pay for their medicines. If you need DARZALEX® and are uninsured and unable to pay for your medicine, please contact a JJPAF program specialist at 1-800-652-6227, 9:00 am to 6:00 pm ET, or visit the foundation website at www.JJPAF.org to see if you might qualify for assistance. For more information on these programs, please call Janssen CarePath at 1-844-55DARZA (1-844-553-2792), Monday through Friday, 8:00 am to 8:00 pm ET, and speak to a Janssen CarePath Care Coordinator. For a comprehensive list of cost support programs related to DARZALEX®, visit www.JanssenPrescriptionAssistance.com/DARZALEX.
The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation. 

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.